Dr. Sanjay S. Shukla | President and Chief Executive Officer |
Jill Broadfoot | Chief Financial Officer |
Ashlee Dunston | Director, Investor Relations and Corporate Communications |
Hartaj Singh | Oppenheimer & Company |
Zegbeh Jallah | ROTH Capital Partners |
Yale Jen | Laidlaw & Company |
Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma First Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question and answer, and instructions will be given the time.
As a reminder, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference call over to Ashlee Dunston, a Tyr's Director of Investor Relations and Corporate Communications.